Prevalence and Baseline Clinical Characteristics of Eosinophilic Chronic Obstructive Pulmonary Disease: A Meta-Analysis and Systematic Review
Authors:
Open Access
- 10 December 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 6, 282
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with different clinical and pathophysiological characteristics. Cumulative evidence shows that eosinophil levels may be connected to the therapeutic effects and phenotype of COPD. However, the prevalence of eosinophilic inflammation in COPD and the baseline characteristics of eosinophilic COPD remain unknown. Our study investigated the prevalence of COPD with eosinophil levels of >2% and the characteristics of eosinophilic COPD. Methods: We searched the Cochrane Central Library, Medline, Embase, and the Web of Science for trials of eosinophil and COPD published from database inception to May 1, 2019. Results: In total, 40,112 COPD patients that were involved in 19 trials were included in the final analysis. The prevalence of eosinophilic COPD ranged from 18.84 to 66.88%, with an average prevalence of 54.95% across all studies. We found that men, ex-smokers, individuals with a history of ischemic heart disease, and individuals with a higher body mass index (BMI) were at higher risk of eosinophilic COPD (OR 1.36, 95% CI 1.26–1.46, P < 0.00001; OR 1.23, 1.12–1.34, P < 0.0001; OR 1.31, 1.14–1.50, P = 0.001; MD 0.70, 0.27–1.12, P = 0.001). There was, however, a lower proportion of GOLD stage I patients among those with eosinophilic COPD (OR 0.84, 0.73–0.96, P = 0.01). No significant differences were found in terms of age, current smoker status, pack-years smoked, percent of predicted forced expiratory volume in 1 s, hypertension, diabetes, or other GOLD stages between the two groups (P > 0.05). Conclusions: Our analysis suggests that eosinophilic inflammation is prevalent in COPD. Eosinophilic COPD was more likely to occur in men, ex-smokers, those with a higher BMI, and those with a high risk of some comorbidity; however, a lower proportion of patients with eosinophilic COPD experienced mild airflow limitations.Keywords
This publication has 41 references indexed in Scilit:
- Penalizing Hospitals for Chronic Obstructive Pulmonary Disease ReadmissionsAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their BiomarkersAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Heightened Endoplasmic Reticulum Stress in the Lungs of Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEuropean Respiratory Journal, 2006
- Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax, 2005
- COPD in Japan: the Nippon COPD Epidemiology studyRespirology, 2004
- Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2000
- Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive BronchitisAmerican Journal of Respiratory and Critical Care Medicine, 1998